Plain-English translation of NCT06732128 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot trial is testing whether nature-based virtual reality—immersive, realistic 3D nature scenes you experience through a headset—can help reduce depression symptoms in people with Alzheimer's disease. About half of people with Alzheimer's experience depression, and existing medications often have side effects. This study explores whether virtual reality nature experiences delivered safely at home could be a helpful new option.
Depression is very common in Alzheimer's disease, but current medications don't work well and can cause serious side effects like falls or cognitive problems. The new treatment aims to offer a safer, accessible alternative that people can use at home without needing to travel to a therapist's office.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to either experience immersive nature-based virtual reality scenes twice per week (15 minutes each session) or to watch nature videos on a tablet. Throughout the study, you would wear a small movement tracker (Fitbit) and a headband that measures brain activity (Muse). A caregiver or family member would be present during each session. The study lasts several weeks with sessions delivered in your home.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Canada